In
many cities and states across the United States, the failure to make
needle exchange programs legal means that the laws limiting access to
sterile needles are being enforced and causing the spread of AIDS. Racial
profiling has meant that black injecting drug users are more likely to
be stopped and searched than are white users.
Thus, racial profiling has also made carrying sterile needles
substantially more risky for black than white users.(1),
(2) Evidence
for racial profiling is substantial and growing:(3)
The
FBI arrest data offer an indication of how racial profiling is affecting
people who use the two most commonly injected drugs, heroin and cocaine.
Among whites, there were five arrests per year per 100 users of
heroin and cocaine in 1996; among blacks, there were 20 arrests per 100
users. In other words, the
arrest rate for black users was four times higher than the arrest rate
for white users.(8), (9) No
research has ever shown that making needle possession illegal has been
effective in reducing drug use in the United States. However, needle possession laws have succeeded in making
sterile needles scarce, causing the spread of HIV, hepatitis C and other
bloodborne diseases. Thus,
abetted by racial profiling, the denial of access to sterile needles has
become a major factor in the spread of deadly diseases.(10) Spreading
HIV/AIDS among African Americans who inject drugs is not the deliberate
policy of any state government or police department.
But, by restricting access to sterile needles and by targeting
black drug users for arrest, that has been the result. Among those who inject drugs, African Americans are five
times as likely as whites to get AIDS.(11) This
must be changed. We need
drug law enforcement that promotes the public welfare not law
enforcement that causes the spread of an incurable disease among African
Americans or any other group. Footnotes (1)
In neighborhoods with heavy injecting drug use, laws prohibiting the
possession of drug paraphernalia are a major reason needles are
sometimes seen lying around in public areas.
People who inject drugs have discarded the needles in haste, as
they have tried to avoid being arrested.
A study in Ohio in 1993 found that 73 percent of the 276 active
drug injectors interviewed feared carrying needles because of drug
paraphernalia laws. See R.
G. Carlson, H. A. Siegal, J. Wang, and R. S. Flack, "Attitudes
Toward Needle 'Sharing' Among Injection Drug Users: Combining
Qualitative and Quantitative Research Methods," Human
Organization,
1996, vol. 55, pp. 361-69. (2)
Sameul L. Groseclose, Beth Weinstein, T. Stephen Jones, Linda A.
Valleroy, Laura J. Fehrs, and William J. Kassler, "Impact of
Increased Legal Access to Needles and Syringes on Practices of
Injection-Drug Users and Police Officers - Connecticut, 1992-1993,"
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology,
vol. 10, pp. 82-29. Alice
A. Gleghorn, T. Stephen Jones, Meg C. Doherty, David D. Celentano, and
David Vlahov, "Acquisition and Use of Needles and Syringes by
Injecting Drug Users in Baltimore, Maryland," Journal of
Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 10,
pp. 97-103. Jean-Paul C.
Grund, Douglas D. Heckathorn, Robert S. Broadhead, and Denise L.
Anthony, "In Eastern Connecticut, IDUs Purchase Syringes from
Pharmacies but Don't Carry Syringes," ," Journal of Acquired
Immune Deficiency Syndromes and Human Retrovirology, vol. 10, pp. 104-5. (3)
Brent Staples, an editorial writer for the New York Times, has pointed
out some of the key consequences of racial profiling apart from the
spread of HIV:
Brent
Staples, "Why Some Get Busted - and some Go
Free," New York Times. May 10, 1999. page
A22. (4)
David Kocieniewski, "U.S. Will Monitor New Jersey Police on Race
Profiling," New York Times. December 23, 1999, page 1. (5)
Kevin Flynn, "Racial Bias Shown in police Searches, State Report
Asserts," New York Times. December 1, 1999, page 1. (6) Page 16. American Civil Liberties Union, Driving While Black: Racial Profiling on Our Nation's Highways, by David A. Harris. June 1999. (7)
Paul Zielbauer, "Racial profiling tops N.A.A.C.P. Agenda," New
York Times. July 11, 1999, page 23.
For further discussion of this issue, see Marcia Davis,
"Traffic violation: racial profiling is a reality for black
drivers." Emerge, June 1999, pages 42-48. (8)
According to unpublished tabulations provided by the FBI, in 1996 there
were 150,000 arrests for possession of heroin and cocaine among whites,
and 127,000 arrests for possession of heroin and cocaine among blacks.
In 1996, there were 3,106,000 whites who used heroin or cocaine
in that year and 638,000 blacks. This
makes for an arrest-to-possession ratio of about 5 in 100 for whites and
20 in 100 for blacks. The
drug use data are from U.S. Dept. of Health and Human Services,
Substance Abuse and Mental Health Services Administration,
National Household Survey on Drug
Abuse: Population Estimates
1996, July 1997, Tables 4B, 4D and 18.
See also Ricky N. Bluthenthal, Alex H. Kral, Jennifer Lorvick,
and John K. Watters. "Impact of Law Enforcement on Syringe Exchange
Programs: A Look at Oakland and San Francisco," Medical
Anthropology, vol. 18, 1997, pp.
1-23. Also, Ricky N.
Bluthenthal, Alex H. Kral, Elizabeth A. Erringer, and Brian R. Edlin. "Drug Paraphernalia Laws and Injection-Related Disease
Risk Among Drug Injectors," Journal of Drug Issues. (9)
For a broad discussion of race and class in the American criminal
justice system, see David Cole, No Equal Justice, New York: The New
Press. 1999. 218 pages. (10)
Peter Lurie and Ernest Drucker, "An
opportunity lost: HIV infections associated with lack of a national
needle-exchange programme in the USA, Lancet,
1997, vol. 349,
March 1, 1997, pp.
604-8. Discrimination by
pharmacies plays a role in preventing African Americans from getting
access to sterile needles. There is evidence from St. Louis, for example, that
drugstores will not always sell syringes to African Americans even when
selling syringes is legal.
University
of California. 1993. The public
health impact of needle exchange programs in the United States and abroad. The
Summary volume can be found in two parts: (A) the "Executive
Summary" and (B) the "Summary,
Conclusions and Recommendations." Peter Lurie, Arthur L.
Reingold, et al., San Francisco:
University of California. Volumes 1 and 2 are available from the
National AIDS Clearinghouse, at 1-800-458-5231. (11)
Based on the number of AIDS cases reported in 1997, according to the CDC
and an analysis by Day and Cohen of household and nonhousehold drug use
as reported by the Substance Abuse and Mental Health Services
Administration's National Household Survey on Drug Abuse: Population
Estimates for 1991-1994. See
Dawn Day and Reuben Cohen, "Race
and the Spread of HIV/AIDS Related to Injection Drug Use," Princeton, NJ:
Dogwood Center, April 1996, 11 pp. Confirming support for this
relationship comes from a CDC survey of HIV seroprevalence among persons
in drug treatment in 1991 and 1992.
In that study, the median HIV seroprevalence for blacks was 18.4
percent; for whites it was 3.8 percent.
CDC, National HIV Serosurveillance Summary: Results through
1992,
vol. 3, p.19. For a list of other materials
used on this website, see References. |